Page last updated: 2024-08-23

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cardiomyopathies, Primary

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Filho, CS; Grings, M; Knebel, LA; Leipnitz, G; Moura, AP; Tonin, AM; Wajner, M; Zanatta, A1

Other Studies

1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cardiomyopathies, Primary

ArticleYear
Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease.
    Molecular and cellular biochemistry, 2012, Volume: 366, Issue:1-2

    Topics: Animals; Antioxidants; Cardiomyopathies; Chromans; Electron Transport Chain Complex Proteins; Glutathione; Homeostasis; In Vitro Techniques; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardium; NADP; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidation-Reduction; Oxidative Stress; Phytanic Acid; Protein Carbonylation; Rats; Rats, Wistar; Refsum Disease; Thiobarbituric Acid Reactive Substances

2012